The effect of core composition in biodegradable oligomeric micelles as taxane formulations

被引:61
作者
Carstens, Myrra G. [1 ,2 ]
de Jong, Pascal H. J. L. F. [1 ]
van Nostrum, Cornelus F. [1 ]
Kemmink, Johan [3 ]
Verrijk, Ruud [2 ]
De Leede, Leo G. J. [2 ]
Crornmelin, Daan J. A. [1 ]
Hennink, Wim E. [1 ]
机构
[1] Univ Utrecht, Dept Pharmaceut, UIPS, NL-3508 TB Utrecht, Netherlands
[2] OctoPlus NV, Leiden, Netherlands
[3] Univ Utrecht, Dept Med Chem, Utrecht, Netherlands
关键词
formulation; polymeric drug carrier; micelle; poly(ethylene glycol)-oligo(epsilon-caprolactone); paclitaxel; docetaxel; particle size; particle stability; drug solubilisation; core composition;
D O I
10.1016/j.ejpb.2007.08.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Docetaxel (DCTX) and paclitaxel (PTX) are very potent anti-cancer drugs, but the currently marketed formulations, Taxotere(R) and Taxol(R), respectively, are associated with vehicle-related toxicity. An attractive alternative to formulate these hydrophobic cytotoxic agents are polymeric micelles. In this study, the loading of taxanes into oligomeric micelles composed of mPEG750-b-oligo(epsilon-caprolactone)(5) (mPEG750-b-OCL5) with a hydroxyl (OH), benzoyl (Bz) or naphthoyl (Np) end group was investigated. Next, the release characteristics and cytotoxicity of the loaded micelles were studied. MPEG750-b-OCL5-OH micelles loaded with taxanes formed unstable particles with rapid leakage of the drug. In contrast, the presence of an aromatic end group (Bz or Np) resulted in the formation of small (10 nm), almost monodisperse micelles with stable encapsulation of 10% (w/w) of PTX or DCTX. This was ascribed to a better compatibility between the micellar core and the drug as compared to the oligomers with the hydroxyl end group. H-1 NMR studies showed that the micellar core was liquid, and that PTX was molecularly dissolved in the core. The in vitro stability was studied in PBS at 37 degrees C, which showed that leakage of PTX from 10% and 5% (w/w) loaded mPEG750-b-OCL5-Bz micelles started after 8 and 24 It, respectively. The presence of albumin did not affect the stability, suggesting that the micelles are not destabilised and the drug was not extracted from the micellar core by this protein. The in vitro cytotoxic effect of the taxane-loaded micelles on C26 carcinoma cells was comparable to that of the commercial formulations, but the empty micelles were far less toxic than the Cremophor EL(R) vehicle. The results show that mPEG-b-oligo(epsilon-caprolactone) micelles hold good promise for the formulation of taxanes. (C) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:596 / 606
页数:11
相关论文
共 60 条
[1]   Development of copolymers of poly(D,L-lactide) and methoxypolyethylene glycol as micellar carriers of paclitaxel [J].
Burt, HM ;
Zhang, XC ;
Toleikis, P ;
Embree, L ;
Hunter, WL .
COLLOIDS AND SURFACES B-BIOINTERFACES, 1999, 16 (1-4) :161-171
[2]   A mechanistic study on the chemical and enzymatic degradation of PEG-Oligo(ε-caprolactone) micelles [J].
Carstens, Myrra G. ;
van Nostrum, Cornelius F. ;
Verrijk, Ruud ;
De Leede, Leo G. J. ;
Crommelin, Daan J. A. ;
Hennink, Wim E. .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2008, 97 (01) :506-518
[3]   Small oligomeric micelles based on end group modified mPEG-oligocaprolactone with monodisperse hydrophobic blocks [J].
Carstens, Myrra G. ;
Bevernage, Jan J. L. ;
van Nostrum, Cornelus F. ;
van Steenbergen, Mies J. ;
Flesch, Frits M. ;
Verrijk, Ruud ;
de Leede, Leo G. J. ;
Crommelin, Daan J. A. ;
Hennink, Wim E. .
MACROMOLECULES, 2007, 40 (01) :116-122
[4]  
*DAYL CHEM INF SYS, CLOGP
[5]   NMRPIPE - A MULTIDIMENSIONAL SPECTRAL PROCESSING SYSTEM BASED ON UNIX PIPES [J].
DELAGLIO, F ;
GRZESIEK, S ;
VUISTER, GW ;
ZHU, G ;
PFEIFER, J ;
BAX, A .
JOURNAL OF BIOMOLECULAR NMR, 1995, 6 (03) :277-293
[6]   Solubilization of docetaxel in poly(ethylene oxide)-block-poly(butylene/styrene oxide) micelles [J].
Elsabahy, Mahmoud ;
Perron, Marie-Eve ;
Bertrand, Nicolas ;
Yu, Ga-er ;
Leroux, Jean-Christophe .
BIOMACROMOLECULES, 2007, 8 (07) :2250-2257
[7]   Alternative drug formulations of docetaxel: a review [J].
Engels, Frederike K. ;
Mathot, Ron A. A. ;
Verweij, Jaap .
ANTI-CANCER DRUGS, 2007, 18 (02) :95-103
[8]   Lipophilic prodrugs of Hsp90 inhibitor geldanamycin for nanoencapsulation in poly(ethylene glycol)-b-poly(ε-caprolactone) micelles [J].
Forrest, M. Laird ;
Zhao, Anni ;
Won, Chee-Youb ;
Malick, A. Waseem ;
Kwon, Glen S. .
JOURNAL OF CONTROLLED RELEASE, 2006, 116 (02) :139-149
[9]   Block copolymer micelles: preparation, characterization and application in drug delivery [J].
Gaucher, G ;
Dufresne, MH ;
Sant, VP ;
Kang, N ;
Maysinger, D ;
Leroux, JC .
JOURNAL OF CONTROLLED RELEASE, 2005, 109 (1-3) :169-188
[10]   THE TAXOIDS - PACLITAXEL AND DOCETAXEL [J].
GELMON, K .
LANCET, 1994, 344 (8932) :1267-1272